Molecular determinants of ivermectin sensitivity at the glycine receptor chloride channel.
Ivermectin is an anthelmintic drug that works by activating glutamate-gated chloride channel receptors (GluClRs) in nematode parasites. GluClRs belong to the Cys-loop receptor family that also includes glycine receptor (GlyR) chloride channels. GluClRs and A288G mutant GlyRs are both activated by low nanomolar ivermectin concentrations. The crystal structure of the Caenorhabditis elegans α GluClR complexed with ivermectin has recently been published. Here, we probed ivermectin sensitivity determinants on the α1 GlyR using site-directed mutagenesis and electrophysiology. Based on a mutagenesis screen of transmembrane residues, we identified Ala288 and Pro230 as crucial sensitivity determinants. A comparison of the actions of selamectin and ivermectin suggested the benzofuran C05-OH was required for high efficacy. When taken together with docking simulations, these results supported a GlyR ivermectin binding orientation similar to that seen in the GluClR crystal structure. However, whereas the crystal structure shows that ivermectin interacts with the α GluClR via H-bonds with Leu218, Ser260, and Thr285 (α GluClR numbering), our data indicate that H-bonds with residues homologous to Ser260 and Thr285 are not important for high ivermectin sensitivity or direct agonist efficacy in A288G α1 GlyRs or three other GluClRs. Our data also suggest that van der Waals interactions between the ivermectin disaccharide and GlyR M2-M3 loop residues are unimportant for high ivermectin sensitivity. Thus, although our results corroborate the ivermectin binding orientation as revealed by the crystal structure, they demonstrate that some of the binding interactions revealed by this structure do not pertain to other highly ivermectin-sensitive Cys-loop receptors.
Queensland Brain Institute, University of Queensland, Brisbane, Queensland 4072.
Timothy
T
Lynagh
Queensland Brain Institute, University of Queensland, Brisbane, Queensland 4072.
Timothy I
TI
Webb
Queensland Brain Institute, University of Queensland, Brisbane, Queensland 4072.
Christine L
CL
Dixon
Health Innovations Research Institute, RMIT University, Melbourne, Victoria 2476, Australia.
Brett A
BA
Cromer
Queensland Brain Institute, University of Queensland, Brisbane, Queensland 4072; School of Biomedical Sciences, University of Queensland, Brisbane, Queensland 4072. Electronic address: j.lynch@uq.edu.au.
Joseph W
JW
Lynch
D000818:Animals; D000977:Antiparasitic Agents / Q000737:chemistry / Q000494:pharmacology; D001572:Benzofurans / Q000737:chemistry; D017173:Caenorhabditis elegans / Q000378:metabolism; D018118:Chloride Channels / Q000737:chemistry*; D018360:Crystallography, X-Ray / Q000379:methods; D003545:Cysteine / Q000737:chemistry; D004594:Electrophysiology / Q000379:methods; D005998:Glycine / Q000737:chemistry; D006860:Hydrogen Bonding; D007559:Ivermectin / Q000031:analogs & derivatives / Q000737:chemistry* / Q000494:pharmacology; D016297:Mutagenesis, Site-Directed; D009154:Mutation; D018009:Receptors, Glycine / Q000737:chemistry*
D000977:Antiparasitic Agents; D001572:Benzofurans; D018118:Chloride Channels; D018009:Receptors, Glycine; C109777:glutamate-gated chloride channels; D007559:Ivermectin; C414354:selamectin; D003545:Cysteine; C105430:benzofuran; D005998:Glycine